Literature DB >> 4019742

Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

P H Gilligan, P A Gage, L M Bradshaw, D V Schidlow, B T DeCicco.   

Abstract

A new medium for the isolation of Pseudomonas cepacia from respiratory tract secretions of patients with cystic fibrosis (CF) is described. This medium consists of inorganic salts, 0.5% pyruvate, and 0.1% proteose peptone as nutritive components and 0.0001% crystal violet, 0.15% bile salts, 100 micrograms of ticarcillin per ml, and 300 U of polymyxin B per ml as selective agents. The medium, designated PC medium, supported superior growth of 38 of 50 stock isolates of P. cepacia after 48 h of incubation when compared with MacConkey agar (0 of 50). The medium completely inhibited the growth of 112 of 124 stock isolates of organisms commonly found in respiratory secretions of CF patients. Cultures were made on PC medium with respiratory secretions of 169 CF patients. P. cepacia was recovered from 35 patients with isolates on PC medium but from only 21 patients with isolates on MacConkey agar. Of 221 other potentially pathogenic isolates found in these specimens, only six (two Pseudomonas aeruginosa isolates, two molds, one yeast, and one Serratia marcescens isolate) grew on PC medium. PC medium should facilitate the recovery of P. cepacia from CF patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019742      PMCID: PMC268309          DOI: 10.1128/jcm.22.1.5-8.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Pseudomonas species in clinical microbiology.

Authors:  G L Gilardi
Journal:  Mt Sinai J Med       Date:  1976 Nov-Dec

Review 2.  Cystic fibrosis: diagnosis, treatment, and prognosis.

Authors:  R E Wood
Journal:  South Med J       Date:  1979-02       Impact factor: 0.954

3.  Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia.

Authors:  D E Craven; B Moody; M G Connolly; N R Kollisch; K D Stottmeier; W R McCabe
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

4.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

5.  Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride.

Authors:  S G Geftic; H Heymann; F W Adair
Journal:  Appl Environ Microbiol       Date:  1979-03       Impact factor: 4.792

6.  Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.

Authors:  A I McKevitt; D E Woods
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

7.  Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.

Authors:  G B Stover; D R Drake; T C Montie
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate.

Authors:  B J Wu; S T Thompson
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

9.  Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water.

Authors:  L A Carson; M S Favero; W W Bond; N J Petersen
Journal:  Appl Microbiol       Date:  1973-03

10.  Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.

Authors:  R Gold; E Jin; H Levison; A Isles; P C Fleming
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

View more
  33 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Microbiological processing of respiratory specimens from patients with cystic fibrosis.

Authors: 
Journal:  Can J Infect Dis       Date:  1993-05

3.  Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.

Authors:  Juyan Zhou; Elizabeth Garber; Manisha Desai; Lisa Saiman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors:  D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Plasmids of Pseudomonas cepacia strains of diverse origins.

Authors:  E Lennon; B T DeCicco
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

6.  Better visualization and photodocumentation of zone of inhibition by staining cells and background agar differently.

Authors:  Mrinal K Bhattacharjee
Journal:  J Antibiot (Tokyo)       Date:  2015-05-13       Impact factor: 2.649

7.  Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.

Authors:  N Cimolai; C Trombley; A G Davidson; L T Wong
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

8.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 10.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.